Japanese drugmaker Takeda Pharmaceutical announced on Thursday that it agreed to acquire Swiss rival Nycomed for roughly $13.7 billion in an effort to expand its presence in Europe and emerging markets.
Deal Watch: Skadden, Sidley, Slaughter and S&C Lead Big Paper Deal, While Private Funds Grow Massive
Featured Firms
Presented by BigVoodoo